Welcome to LookChem.com Sign In|Join Free

CAS

  • or
D-2-Amino-4-methylpentanoic acid, also known as D-Leucine, is an optical isomer of leucine with the D-configuration. It is a white powder and is a crucial component in the formation of sterols. D-Leucine is also utilized as a selectable marker in various applications.

328-38-1

Post Buying Request

328-38-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

328-38-1 Usage

Uses

Used in Pharmaceutical Industry:
D-2-Amino-4-methylpentanoic acid is used as a building block for the synthesis of various pharmaceutical compounds, particularly due to its role in the formation of sterols. Sterols are essential components of cell membranes and have significant implications in human health and disease.
Used in Biotechnology:
D-2-Amino-4-methylpentanoic acid serves as a selectable marker in biotechnology, particularly in the field of genetic engineering. As a selectable marker, it aids in the identification and selection of genetically modified cells or organisms, facilitating the process of genetic manipulation and research.
Used in Nutritional Supplements:
D-Leucine, as D-2-Amino-4-methylpentanoic acid, is also used in the formulation of nutritional supplements. It plays a vital role in protein synthesis and has been shown to have potential benefits in muscle growth, recovery, and overall health.

Check Digit Verification of cas no

The CAS Registry Mumber 328-38-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,2 and 8 respectively; the second part has 2 digits, 3 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 328-38:
(5*3)+(4*2)+(3*8)+(2*3)+(1*8)=61
61 % 10 = 1
So 328-38-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2/c1-4(2)3-5(7)6(8)9/h4-5H,3,7H2,1-2H3,(H,8,9)/t5-/m1/s1

328-38-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (L0027)  D-Leucine  >98.0%(T)

  • 328-38-1

  • 5g

  • 190.00CNY

  • Detail
  • TCI America

  • (L0027)  D-Leucine  >98.0%(T)

  • 328-38-1

  • 25g

  • 690.00CNY

  • Detail
  • Alfa Aesar

  • (A14842)  D-Leucine, 99%   

  • 328-38-1

  • 5g

  • 423.0CNY

  • Detail
  • Alfa Aesar

  • (A14842)  D-Leucine, 99%   

  • 328-38-1

  • 25g

  • 1592.0CNY

  • Detail
  • Alfa Aesar

  • (A14842)  D-Leucine, 99%   

  • 328-38-1

  • 100g

  • 5104.0CNY

  • Detail
  • Vetec

  • (V900646)  D-Leucine  Vetec reagent grade, 97%

  • 328-38-1

  • V900646-5G

  • 65.52CNY

  • Detail
  • Vetec

  • (V900646)  D-Leucine  Vetec reagent grade, 97%

  • 328-38-1

  • V900646-25G

  • 262.08CNY

  • Detail
  • Aldrich

  • (855448)  D-Leucine  ReagentPlus®, 99%

  • 328-38-1

  • 855448-2.5G

  • 451.62CNY

  • Detail
  • Aldrich

  • (855448)  D-Leucine  ReagentPlus®, 99%

  • 328-38-1

  • 855448-10G

  • 1,333.80CNY

  • Detail
  • Aldrich

  • (855448)  D-Leucine  ReagentPlus®, 99%

  • 328-38-1

  • 855448-25G

  • 2,039.31CNY

  • Detail

328-38-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name D-leucine

1.2 Other means of identification

Product number -
Other names leucine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:328-38-1 SDS

328-38-1Synthetic route

N-(9-fluorenylmethoxycarbonyl)-D-leucine
35661-60-0, 126727-03-5, 114360-54-2

N-(9-fluorenylmethoxycarbonyl)-D-leucine

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With piperidine In N,N-dimethyl-formamide at 20℃;100%
(R)-N-benzylleucine
89384-51-0

(R)-N-benzylleucine

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In acetic acid for 24h;98%
(R)-2-azido-4-methylpentanoic acid
126191-08-0

(R)-2-azido-4-methylpentanoic acid

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With hydrogen; palladium on activated charcoal In water; acetic acid under 760 Torr; for 4h;92%
D-α-Hydrazino-isocapronsaeure
24292-07-7

D-α-Hydrazino-isocapronsaeure

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With hydrogen; platinum(IV) oxide91%
(R)-2-Amino-4-methyl-pentanoic acid ((1S,2S)-2-hydroxy-1-methyl-2-phenyl-ethyl)-methyl-amide
170642-24-7

(R)-2-Amino-4-methyl-pentanoic acid ((1S,2S)-2-hydroxy-1-methyl-2-phenyl-ethyl)-methyl-amide

A

(R)-leucine
328-38-1

(R)-leucine

B

pseudoephedrine
90-82-4

pseudoephedrine

Conditions
ConditionsYield
With water for 10h; Heating;A 86%
B n/a
(R)-2-Amino-4-methyl-pentanoic acid ((1S,2S)-2-hydroxy-1-methyl-2-phenyl-ethyl)-methyl-amide
170642-24-7

(R)-2-Amino-4-methyl-pentanoic acid ((1S,2S)-2-hydroxy-1-methyl-2-phenyl-ethyl)-methyl-amide

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
In water for 10h; Heating; other reagent;86%
4-methyl-2-oxopentanoic acid
816-66-0

4-methyl-2-oxopentanoic acid

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With D-glucose; Bacillus subtilis glucose dehydrogenase; Symbiobacterium thermophilum meso-Diaminopimelate dehydrogenase W121L/H227I mutant; NADP; ammonium chloride In aq. buffer at 37℃; for 24h; pH=8.5; Kinetics; Reagent/catalyst; Enzymatic reaction;68%
With D-Alanine; meso-diaminopimelate dehydrogenase; pyridoxal 5'-phosphate; alcohol dehydrogenases from Bacillus stearothermophilus; alcohol dehydrogenases from Thermoanaerobacter brockii; NADH In isopropyl alcohol at 35℃; for 12h; pH=8; Reagent/catalyst; Enzymatic reaction; enantioselective reaction;53.2%
With meso-2,6-D-diaminopimelic acid dehydrogenase mutant BC621; ammonium chloride; NADPH In various solvent(s) for 24h;
With D-amino acid transaminase; D-Alanine; R-selective ω-transaminase from Arthrobacter sp; (3-hydroxy-5-hydroxymethyl)-2-methylisonicotinic acid 5-phosphate; isopropylamine In aq. phosphate buffer for 7h; pH=7;n/a
With D-Glucose; Bacillus megaterium glucose dehydrogenase; ammonia; Symbiobacterium thermophilum mesodiaminopimelate dehydrogenase Enzymatic reaction;n/a
sodium 4-methyl-2-oxovalerate
4502-00-5

sodium 4-methyl-2-oxovalerate

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With zinc(II) perchlorate; (S)-15-amino-methyl-14-hydroxy-5,5-dimethyl-2,8-dithia<9>(2,5)pyridinophane In methanol for 24h; Ambient temperature;66%
LEUCINE
328-39-2

LEUCINE

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With yeast; Sucrose
beim Durchgang durch den Organismus des Kaninchens;
With penicillium glaucum
DL-leucine ethyl ester
2899-43-6

DL-leucine ethyl ester

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With (-)-(R,R)-dibenzoyltartaric acid
N-formyl-valine
5338-45-4

N-formyl-valine

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With ethanol; brucine man filtriert das sich ausscheid.Brucinsalz des Formyl-d-leucins ab,zerlegt es durch Natronlauge u.verseift das erhalt.Formyl-d-leucin durch Kochen mit 10prozentig.Salzsaeure o.durch Schuetteln mit 30prozentig.Bromwasserstoffsaeure b.37grad;
Conditions
ConditionsYield
Hydrolysis;
N-chloroacetyl-D-leucine
64830-83-7

N-chloroacetyl-D-leucine

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With hydrogenchloride
Z-D-Leu-OH
28862-79-5

Z-D-Leu-OH

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With hydrogenchloride; palladium Hydrogenation;
LEUCINE
328-39-2

LEUCINE

A

(R)-leucine
328-38-1

(R)-leucine

B

L-leucine
61-90-5

L-leucine

N-acetyl-D-leucine
19764-30-8

N-acetyl-D-leucine

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
In water at 37℃; for 0.166667h; Rate constant; D-aminocyclase from Alcaligenes denitrificans DA181, pH 7.8, bovine serum albumin;
With D-aminoacylase from Alcaligenes xylosoxydans Enzyme kinetics; Further Variations:; Reagents; Deacetylation;
isobutyl triflate
60306-25-4

isobutyl triflate

trans-(2S,5S)-N--2,5-bis(methoxymethoxymethyl)pyrrolidine
108437-90-7

trans-(2S,5S)-N--2,5-bis(methoxymethoxymethyl)pyrrolidine

A

(R)-leucine
328-38-1

(R)-leucine

B

L-leucine
61-90-5

L-leucine

Conditions
ConditionsYield
Yield given. Multistep reaction. Yields of byproduct given;
glycyl-L-leucylglycylglycine
7325-21-5

glycyl-L-leucylglycylglycine

A

(R)-leucine
328-38-1

(R)-leucine

B

[(S)-2-(2-Amino-acetylamino)-4-methyl-pentanoylamino]-acetic acid
2576-67-2

[(S)-2-(2-Amino-acetylamino)-4-methyl-pentanoylamino]-acetic acid

C

glycyl-D-leucylglycine
131830-34-7

glycyl-D-leucylglycine

D

glycyl-D-leucylglycylglycine
117760-61-9

glycyl-D-leucylglycylglycine

E

cyclo(glycyl-L-leucyl)
5815-67-8, 5845-67-0, 108315-75-9

cyclo(glycyl-L-leucyl)

F

cyclo-(glycyl-D-leucyl)
108315-75-9

cyclo-(glycyl-D-leucyl)

Conditions
ConditionsYield
In various solvent(s) at 148.5℃; Product distribution; Rate constant; rate of racemization was investigated during decomposition;
Leucine p-nitrophenyl ester
17663-34-2, 66575-12-0

Leucine p-nitrophenyl ester

A

(R)-leucine
328-38-1

(R)-leucine

B

L-leucine
61-90-5

L-leucine

Conditions
ConditionsYield
With (R)-<methyl>pyridine; copper(II) ion In various solvent(s) at 25℃; Rate constant; enantioselectivity of cleavage; other chiral ligands;
(2R,2'R)-N-(2'-amino-4'-methylpentanoyl)bornane-10,2-sultam
129568-83-8

(2R,2'R)-N-(2'-amino-4'-methylpentanoyl)bornane-10,2-sultam

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With lithium hydroxide; ion exchange 1.) THF; Yield given. Multistep reaction;
With lithium hydroxide; Amberlite IR-120 1) THF, room temperature, 2) H2O, room temperature, 15 h; Yield given. Multistep reaction;
theonellamine B
105091-14-3, 119816-11-4

theonellamine B

A

N-methylalanine
3913-67-5

N-methylalanine

B

L-valine
72-18-4

L-valine

C

L-threonine
72-19-5

L-threonine

D

N-methyl-L-valine
2480-23-1

N-methyl-L-valine

E

(R)-leucine
328-38-1

(R)-leucine

F

3-amino propanoic acid
107-95-9

3-amino propanoic acid

Conditions
ConditionsYield
With hydrogenchloride at 110℃; for 4h;
theonellamine B
105091-14-3, 119816-11-4

theonellamine B

A

L-valine
72-18-4

L-valine

B

N-methyl-L-valine
2480-23-1

N-methyl-L-valine

C

(R)-leucine
328-38-1

(R)-leucine

D

3-amino propanoic acid
107-95-9

3-amino propanoic acid

Conditions
ConditionsYield
With hydrogenchloride at 110℃; for 40h; Further byproducts given;
(R)-2-Azido-4-methyl-pentanoic acid benzyl ester

(R)-2-Azido-4-methyl-pentanoic acid benzyl ester

A

(R)-leucine
328-38-1

(R)-leucine

B

L-leucine
61-90-5

L-leucine

Conditions
ConditionsYield
With hydrogen; Pd-BaSO4 In ethanol under 760 Torr; Ambient temperature; Yield given. Yields of byproduct given;
ulithiacyclamide A
74847-09-9

ulithiacyclamide A

A

L-threonine
72-19-5

L-threonine

B

(R)-leucine
328-38-1

(R)-leucine

C

L-cystine
56-89-3

L-cystine

Conditions
ConditionsYield
With triphenyl phosphite; oxygen In dichloromethane Product distribution; Ambient temperature; configuration;
L-leucine (phenylmethyl)ester
80089-22-1

L-leucine (phenylmethyl)ester

A

(R)-leucine
328-38-1

(R)-leucine

B

L-leucine
61-90-5

L-leucine

C

L-Leucine benzyl ester
1738-69-8

L-Leucine benzyl ester

D

D-leucine benzyl ester
46741-65-5

D-leucine benzyl ester

Conditions
ConditionsYield
With sodium bicarbonate buffer; subtilisin 8350 at 35℃; for 1h; Product distribution; var. DL-amino acid esters;
9-fluorenylmethyloxycarbonyl-L-leucine anhydride
70626-37-8

9-fluorenylmethyloxycarbonyl-L-leucine anhydride

A

(R)-leucine
328-38-1

(R)-leucine

B

L-leucine
61-90-5

L-leucine

Conditions
ConditionsYield
With dmap; p-hydroxymethylphenoxyacetyl-polydimethylacrylamide resin; trifluoroacetic acid Product distribution; racemisation in dependence on sequence of addition of reagents; 1) dimethylacetamide, 3 h;
N-carbamyl-D-leucine
54896-73-0

N-carbamyl-D-leucine

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With potassium phosphate buffer; Pseudomonas sp. AJ-11220 In various solvent(s) at 30℃; for 2h;
With hydrogenchloride; sodium nitrite at 0℃;
With potassium phosphate buffer; Pseudomonas sp. AJ-11220 In various solvent(s) at 30℃; for 2h; pH 7.5; enzymatic reaction;
5-isobutyl-imidazolidine-2,4-dione
67337-73-9

5-isobutyl-imidazolidine-2,4-dione

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
at 37℃; Pseudomonas Sp.;
diethylaluminium cyanide
5804-85-3

diethylaluminium cyanide

2-Methoxy-naphthalene-1-sulfinic acid [3-methyl-but-(E)-ylidene]-amide

2-Methoxy-naphthalene-1-sulfinic acid [3-methyl-but-(E)-ylidene]-amide

(R)-leucine
328-38-1

(R)-leucine

Conditions
ConditionsYield
With hydrogenchloride 1.) THF, from -78 to -40 degC; 2.) reflux; Yield given. Multistep reaction;
methanol
67-56-1

methanol

(R)-leucine
328-38-1

(R)-leucine

(R)-leucine methyl ester hydrochloride
5845-53-4, 6322-53-8, 7517-19-3

(R)-leucine methyl ester hydrochloride

Conditions
ConditionsYield
With sulfuryl dichloride at 0 - 20℃; for 16h; Inert atmosphere;100%
With thionyl chloride at 20℃;99%
With thionyl chloride for 12h; Ambient temperature;94%
(R)-leucine
328-38-1

(R)-leucine

benzyl chloroformate
501-53-1

benzyl chloroformate

Z-D-Leu-OH
28862-79-5

Z-D-Leu-OH

Conditions
ConditionsYield
With sodium hydroxide In water at 0 - 20℃;100%
With sodium hydroxide In water at 20℃; for 2h;90%
With sodium hydrogencarbonate87%
Stage #1: (R)-leucine With sodium hydroxide In water at 0℃; Cooling with ice;
Stage #2: benzyl chloroformate In 1,4-dioxane; water at 20℃;
With sodium hydroxide In 1,4-dioxane at 0 - 20℃;
ethanol
64-17-5

ethanol

(R)-leucine
328-38-1

(R)-leucine

D-(-)-leucine ethyl ester hydrochloride
73913-65-2

D-(-)-leucine ethyl ester hydrochloride

Conditions
ConditionsYield
With thionyl chloride for 4h; Reflux;100%
With hydrogenchloride Heating;87%
phthalic anhydride
85-44-9

phthalic anhydride

(R)-leucine
328-38-1

(R)-leucine

(R)-2-(1,3-dioxoisoindolin-2-yl)-4-methylpentanoic acid
29588-87-2

(R)-2-(1,3-dioxoisoindolin-2-yl)-4-methylpentanoic acid

Conditions
ConditionsYield
for 0.0611111h; microwave irradiation;98%
at 150℃;
(R)-leucine
328-38-1

(R)-leucine

N-1-naphthalenesulfonyl-D-leucine
68305-80-6

N-1-naphthalenesulfonyl-D-leucine

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane98%
(R)-leucine
328-38-1

(R)-leucine

1-Naphthalenesulfonyl chloride
85-46-1

1-Naphthalenesulfonyl chloride

N-1-naphthalenesulfonyl-D-leucine
202326-38-3

N-1-naphthalenesulfonyl-D-leucine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane at 0 - 20℃; for 4h; pH=9 - 10;98%
(R)-leucine
328-38-1

(R)-leucine

di-tert-butyl dicarbonate
24424-99-5

di-tert-butyl dicarbonate

N-Boc-D-Leu
16937-99-8

N-Boc-D-Leu

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane at 0 - 20℃; Inert atmosphere;97%
Stage #1: (R)-leucine With sodium hydroxide In tetrahydrofuran; water for 0.25h; Inert atmosphere; Cooling with ice;
Stage #2: di-tert-butyl dicarbonate In tetrahydrofuran; water at 20℃; for 24h; pH=Ca. 10.5; Inert atmosphere; Cooling with ice;
97.2%
Stage #1: (R)-leucine With potassium carbonate In acetone at 20℃; for 0.0833333h;
Stage #2: di-tert-butyl dicarbonate In acetone
95%
(R)-leucine
328-38-1

(R)-leucine

tetrachlorophthalic anhydride
117-08-8

tetrachlorophthalic anhydride

TCP-D-Leu-OH

TCP-D-Leu-OH

Conditions
ConditionsYield
In N,N-dimethyl-formamide Microwave irradiation;97%
N-succinimidyl 3,5-dichlorobenzoate
143558-02-5

N-succinimidyl 3,5-dichlorobenzoate

(R)-leucine
328-38-1

(R)-leucine

(R)-N-(3,5-dichlorobenzoyl)leucine

(R)-N-(3,5-dichlorobenzoyl)leucine

Conditions
ConditionsYield
With sodium hydrogencarbonate In tetrahydrofuran; water at 20℃; for 18h;97%
(R)-leucine
328-38-1

(R)-leucine

4-bromobenzenesulfonyl chloride
98-58-8

4-bromobenzenesulfonyl chloride

N-p-bromo-benzenesulfonyl-D-leucine
68305-78-2

N-p-bromo-benzenesulfonyl-D-leucine

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane96.4%
(R)-leucine
328-38-1

(R)-leucine

4-bromobenzenesulfonyl chloride
98-58-8

4-bromobenzenesulfonyl chloride

N-p-bromobenzenesulfonyl-D-leucine
1308991-43-6

N-p-bromobenzenesulfonyl-D-leucine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane at 0 - 20℃; for 4h; pH=9 - 10;96.4%
(R)-leucine
328-38-1

(R)-leucine

benzyl alcohol
100-51-6

benzyl alcohol

D-leucine benzyl ester
46741-65-5

D-leucine benzyl ester

Conditions
ConditionsYield
With toluene-4-sulfonic acid In benzene for 16h; Heating;95%
(R)-leucine
328-38-1

(R)-leucine

cyclohexanylcarbonyl chloride
2719-27-9

cyclohexanylcarbonyl chloride

(R)-2-(cyclohexanecarboxamido)-4-methylpentanoic acid

(R)-2-(cyclohexanecarboxamido)-4-methylpentanoic acid

Conditions
ConditionsYield
With potassium phosphate In tetrahydrofuran for 24h; Inert atmosphere;94%
With sodium hydroxide for 2.5h; Ambient temperature;
(R)-leucine
328-38-1

(R)-leucine

4-Fluorobenzenesulfonyl chloride
349-88-2

4-Fluorobenzenesulfonyl chloride

N-p-fluorobenzenesulfonyl-D-leucine

N-p-fluorobenzenesulfonyl-D-leucine

Conditions
ConditionsYield
With sodium hydroxide In 1,4-dioxane at 0 - 20℃; for 4h; pH=9 - 10;94%
With sodium carbonate In water
(R)-leucine
328-38-1

(R)-leucine

di(μ-chloro)bis[1-(phenylazo)phenyl-C(2)N]dipalladium(II)
14873-53-1

di(μ-chloro)bis[1-(phenylazo)phenyl-C(2)N]dipalladium(II)

Pd(C6H4NNC6H5)(NH2CH(CH2CH(CH3)2)CO2)

Pd(C6H4NNC6H5)(NH2CH(CH2CH(CH3)2)CO2)

Conditions
ConditionsYield
With NaOMe In methanol N2-atmosphere; dropwise addn. of 1 equiv. NaOMe to aminoacid, gentle heating to dissoln., addn. of stoich. amt. Pd-complex, stirring for 15 h; solvent removal (vac.), dissoln. in CH2Cl2, centrifugation, solvent removal (vac.); elem. anal.;94%
(R)-leucine
328-38-1

(R)-leucine

4-Fluorobenzenesulfonyl chloride
349-88-2

4-Fluorobenzenesulfonyl chloride

N-p-fluoro-benzenesulfonyl-D-leucine

N-p-fluoro-benzenesulfonyl-D-leucine

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane94%
(R)-leucine
328-38-1

(R)-leucine

(R)-2-hydroxy-4-methylpentanoic acid
20312-37-2

(R)-2-hydroxy-4-methylpentanoic acid

Conditions
ConditionsYield
With sulfuric acid; sodium nitrite In water at 5 - 20℃;93.8%
With sulfuric acid; sodium nitrite at 0℃;79%
With sulfuric acid; water; sodium nitrite76%
methanol
67-56-1

methanol

(R)-leucine
328-38-1

(R)-leucine

D-leucine methyl ester
23032-21-5

D-leucine methyl ester

Conditions
ConditionsYield
With thionyl chloride for 6h; Ambient temperature;91%
With chlorosulfonic acid at 20℃; for 2h;80%
With hydrogenchloride
(R)-leucine
328-38-1

(R)-leucine

N-t-butoxycarbonyl-(R)-proline N-hydroxysuccuinimide ester
102185-34-2

N-t-butoxycarbonyl-(R)-proline N-hydroxysuccuinimide ester

N-(tert-butoxycarbonyl)-(R)-prolyl-(R)-leucine
91711-95-4

N-(tert-butoxycarbonyl)-(R)-prolyl-(R)-leucine

Conditions
ConditionsYield
With sodium hydroxide; potassium hydrogencarbonate In 1,4-dioxane 1.) 0 deg C, overnight; 2.) r.t., 24 h;90%
(R)-leucine
328-38-1

(R)-leucine

acetic anhydride
108-24-7

acetic anhydride

N-acetyl-D-leucine
19764-30-8

N-acetyl-D-leucine

Conditions
ConditionsYield
Stage #1: (R)-leucine; acetic anhydride With sodium hydroxide In water at 5 - 15℃; for 4 - 5h;
Stage #2: With hydrogenchloride In water at 5 - 15℃; for 2.5h;
89%
Stage #1: (R)-leucine; acetic anhydride With sodium hydroxide In water at 5 - 15℃; for 2h; pH=8-9; Inert atmosphere; Large scale;
Stage #2: With hydrogenchloride In water at 5 - 15℃; for 2.5h; Inert atmosphere; Large scale;
89%
With sodium hydroxide In water at 20℃; pH=14;
In tetrahydrofuran; water
(R)-leucine
328-38-1

(R)-leucine

2,7-disulfo-9-fluorenylmethoxycarbonyl chloride

2,7-disulfo-9-fluorenylmethoxycarbonyl chloride

C21H21NO10S2(2-)*2Na(1+)

C21H21NO10S2(2-)*2Na(1+)

Conditions
ConditionsYield
With sodium hydrogencarbonate In water; acetonitrile at 20℃; for 0.5h; pH=8.5;88.7%
(R)-leucine
328-38-1

(R)-leucine

N-((1S,2R,4aS,5R,8aS)-2-hydroxy-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)ethenyl)decahydronaphthalen-1-yl)formamide

N-((1S,2R,4aS,5R,8aS)-2-hydroxy-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)ethenyl)decahydronaphthalen-1-yl)formamide

(S)-(1S,2R,4aS,5R,8aS)-1-formamido-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)ethenyl)decahydronaphthalen-2-yl 2-amino-4-methylpentanoate

(S)-(1S,2R,4aS,5R,8aS)-1-formamido-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)ethenyl)decahydronaphthalen-2-yl 2-amino-4-methylpentanoate

Conditions
ConditionsYield
Stage #1: (R)-leucine With dicyclohexyl-carbodiimide In dichloromethane for 0.333333h;
Stage #2: N-((1S,2R,4aS,5R,8aS)-2-hydroxy-1,4a-dimethyl-6-methylene-5-((E)-2-(2-oxo-2,5-dihydrofuran-3-yl)ethenyl)decahydronaphthalen-1-yl)formamide With dmap In dichloromethane at 20℃; for 2h;
88%
(R)-leucine
328-38-1

(R)-leucine

(1R,2S,5R)-menthyl chloroformate
14602-86-9

(1R,2S,5R)-menthyl chloroformate

N-[(-)-menthoxylcarbonyl]-D-leucine
1627153-13-2

N-[(-)-menthoxylcarbonyl]-D-leucine

Conditions
ConditionsYield
With sodium hydroxide In water at 0℃; for 0.5h; Schlenk technique; Inert atmosphere;87%
(R)-leucine
328-38-1

(R)-leucine

(R)-2-bromo-4-methylpentanoic acid
42990-28-3

(R)-2-bromo-4-methylpentanoic acid

Conditions
ConditionsYield
With hydrogen bromide; sodium nitrite In water at 0℃; for 2.5h;86%
With hydrogen bromide; sodium nitrite In water at 0℃; for 2.5h; Inert atmosphere;85%
With potassium bromide; sodium nitrite In water83%

328-38-1Relevant articles and documents

Role of conserved histidine residues in D-aminoacylase from Alcaligenes xylosoxydans subsp. xylosoxydans A-6

Wakayama, Mamoru,Yada, Harutaka,Kanda, Shun-Ichi,Hayashi, Shin-Ichi,Yatsuda, Yukinori,Sakai, Kenji,Moriguchi, Mitsuaki

, p. 1 - 8 (2000)

D-Aminoacylase from Alcaligenes xylosoxydans subsp. xylosoxydans A-6 (Alcaligenes A-6) was strongly inactivated by diethylpyrocarbonate (DEPC). An H67N mutant was barely active, with a kcat/Km 6.3 × 104 times lower than that of the recombinant wild-type enzyme, while the H67I mutant lost detectable activity. The H67N mutant had almost constant Km, but greatly decreased kcat. These results suggested that His67 is essential to the catalytic event. Both H69N and H69I mutants were overproduced in the insoluble fraction. The kcat/Km of H250N mutant was reduced by a factor of 2.5 × 104-old as compared with the wild-type enzyme. No significant difference between H251N mutant and wild-type enzymes in the Km and kcat was found. The Zn content of H250N mutant was nearly half of that of wild-type enzyme. These results suggest that the His250 residue might be essential to catalysis via Zn binding.

Structures and antitumor activities of ten new and twenty known surfactins from the deep-sea bacterium Limimaricola sp. SCSIO 53532

Chen, Min,Chen, Rouwen,Ding, Wenping,Li, Yanqun,Tian, Xinpeng,Yin, Hao,Zhang, Si

, (2022/01/11)

Surfactins are natural biosurfactants with myriad potential applications in the areas of healthcare and environment. However, surfactins were almost exclusively produced by the bacterium Bacillus species in previous reported literatures, together with difficulty in isolating pure monomer, which resulted in making extensive effort to remove duplication and little discovery of new surfactins in recent years. In the present study, the result of Molecular Networking indicated that Limimaricola sp. SCSIO 53532 might well be a potential resource for surfacin-like compounds based on OSMAC strategy. To search for new surfactins with significant biological activity, further study was undertaken on the strain. As a result, ten new surfactins (1–10), along with twenty known surfactins (11–30), were isolated from the ethyl acetate extract of SCSIO 53532. Their chemical structures were established by detailed 1D and 2D NMR spectroscopy, HRESIMS data, secondary ion mass spectrometry (MS/MS) analysis, and chemical degradation (Marfey's method) analysis. Cytotoxic activities of twenty-seven compounds against five human tumor cell lines were tested, and five compounds showed significant antitumor activities with IC50 values less than 10 μM. Furtherly, analysis of structure–activity relationships revealed that the branch of side chain, the esterification of Glu or Asp residue, and the amino acid residue of position 7 possessed a great influence on antitumor activity.

Adiponectin-Secretion-Promoting Cyclic Peptide-Polyketide Hybrids from a Halophyte-Associated Fungus, Colletotrichum gloeosporioides JS0417

An, Seungchan,Bang, Sunghee,Deyrup, Stephen T.,Gong, Junpyo,Kim, Jaekyeong,Ko, Hyejin,Lee, Changyeol,Noh, Minsoo,Shim, Sang Hee

, (2022/03/02)

Three new cyclic peptide-polyketide hybrids (1-3) and two new chaetiacandin-type polyketides (4 and 5) along with nine known compounds were isolated from cultures of a halophyte-associated fungus, Colletotrichum gloeosporioides JS0417. Spectroscopic analysis revealed that 1-3 were cyclic depsipeptides where 3,5,11-trihydroxy-2,6-dimethyldodecanoic acid was linked to two amino acids through amide and ester bonds to form a 12-membered ring. Relative and absolute configurations for the peptides were determined with spectroscopic analysis and chemical reactions. The cyclic depsipeptides 2 and 6 were determined to act as strong adiponectin-secretion-promoting modulators with potential to treat metabolic diseases associated with hypoadiponectinemia. Notably, a known compound, tryptophol, significantly inhibited PGE2synthesis and also promoted adiponectin secretion, exhibiting a similar biological activity profile to aspirin, but with greater potency. The presence of an isoleucine moiety and non-glycosylation may be important for biological activity of the cyclic peptide-polyketide hybrids, and non-methoxylation of the side chain may influence activity of the indole derivatives.

Structures and Biosynthetic Pathway of Coprisamides C and D, 2-Alkenylcinnamic Acid-Containing Peptides from the Gut Bacterium of the Carrion Beetle Silpha perforata

Shin, Yern-Hyerk,Ban, Yeon Hee,Kim, Tae Ho,Bae, Eun Seo,Shin, Jongheon,Lee, Sang Kook,Jang, Jichan,Yoon, Yeo Joon,Oh, Dong-Chan

, (2021/02/26)

Coprisamides C and D (1 and 2) were isolated from a gut bacterium, Micromonospora sp. UTJ3, of the carrion beetle Silpha perforata. Based on the combined analysis of UV, MS, and NMR spectral data, the planar structures of 1 and 2 were elucidated to be unreported derivatives of coprisamides A and B, cyclic depsipeptides bearing a 2-alkenylcinnamic acid unit and the unusual amino acids β-methylaspartic acid and 2,3-diaminopropanoic acid. The absolute configuration of 1 was determined using the advanced Marfey's method, phenylglycine methyl ester derivatization, and J-based configuration analysis. The biosynthetic gene clusters for the coprisamides were investigated based on genomic data from coprisamide-producing strains Micromonospora sp. UTJ3 and Streptomyces sp. SNU533. Coprisamide C (1) was active against the Mycobacterium tuberculosis mc26230 strain.

Single-step fluorescent probes to detect decrotonylation activity of HDACs through intramolecular reactions

Xie, Yusheng,Yang, Liu,Chen, Qingxin,Zhang, Jie,Feng, Ling,Chen, Jian Lin,Hao, Quan,Zhang, Liang,Sun, Hongyan

, (2021/01/11)

Lysine crotonylation plays vital roles in gene transcription and cellular metabolism. Nevertheless, methods for dissecting the molecular mechanisms of decrotonyaltion remains limited. So far, there is no single-step fluorescent method developed for enzymatic decrotonylation activity detection. The major difficulty is that the aliphatic crotonylated lysine doesn't allow π-conjugation to a fluorophore and decrotonylation can not modulate the electronic state directly. Herein, we have designed and synthesized two activity-based single-step fluorogenic probes KTcr-I and KTcr-II for detecting enzymatic decrotonylation activity. These two probes can be recognized by histone deacetylases and undergo intramolecular nucleophilic exchange reaction to generate fluorescence signal. Notably, peptide sequence-dependent effect was observed. KTcr-I can be recognized by Sirt2 more effectively, while KTcr-II with LGKcr peptide sequence preferentially reacted with HDAC3. Compared to other methods of studying enzymatic decrotonylation activity, our single-step fluorescent method has a number of advantages, such as facileness, high sensitivity, cheap facility and little material consumed. We envision that the probes developed in this study will provide useful tools to screen inhibitors which suppress the decrotonylation activity of HDACs. Such probes will be useful for further delineating the roles of decrotonylation enzyme and aid in biomarker identification and drug discovery.

Exploration of Transaminase Diversity for the Oxidative Conversion of Natural Amino Acids into 2-Ketoacids and High-Value Chemicals

Chen, Yanchun,Cui, Xuexian,Cui, Yinglu,Li, Chuijian,Li, Ruifeng,Li, Tao,Sun, Jinyuan,Wu, Bian,Zhu, Tong

, p. 7950 - 7957 (2020/08/21)

The use of 2-ketoacids is very common in feeds, food additives, and pharmaceuticals, and 2-ketoacids are valuable precursors for a plethora of chemically diverse compounds. Biocatalytic synthesis of 2-ketoacids starting from l-amino acids would be highly desirable because the substrates are readily available from biomass feedstock. Here, we report bioinformatic exploration of a series of aminotransferases (ATs) to achieve the desired conversion. Thermodynamic control was achieved by coupling an l-glutamate oxidation reaction in the cascade for the recycling of the amine acceptor. These enzymes were able to convert a majority of proteinogenic amino acids into the corresponding 2-ketoacids with high conversion (up to 99percent) and atom-efficiency. Furthermore, this enzyme cascade was extendable, and one-pot two-step processes were established for the synthesis of d-amino acids and N-methylated amino acids, achieving great overall conversion (up to 99percent) and high ee values (>99percent). These developed enzymatic methodologies offer convenient routes for utilizing amino acids as synthetic reagents.

Krisynomycins, Imipenem Potentiators against Methicillin-Resistant Staphylococcus aureus, Produced by Streptomyces canus

De La Cruz, Mercedes,Genilloud, Olga,González, Ignacio,Martín, Jesús,Oves-Costales, Daniel,Pérez-Bonilla, Mercedes,Reyes, Fernando,Vicente, Francisca

, p. 2597 - 2606 (2020/10/12)

A reinvestigation of the acetone extract of the strain CA-091830 of Streptomyces canus, producer of the imipenem potentiator krisynomycin, resulted in the isolation of two additional analogues, krisynomycins B (1) and C (2), with different chlorination patterns. Genome sequencing of the strain followed by detailed bioinformatics analysis led to the identification of the corresponding biosynthetic gene cluster (BGC) of this cyclic nonribosomal peptide family. The planar structure of the new molecules was determined using HRMS, ESI-qTOF-MS/MS, and 1D and 2D NMR data. Their absolute configuration was proposed using a combination of Marfey's and bioinformatic BGC analyses. The krisynomycins displayed weak to negligible antibiotic activity against methicillin-resistant Staphylococcus aureus (MRSA), which was significantly enhanced when tested in combination with sublethal concentrations of imipenem. The halogenation pattern plays a key role in the antimicrobial activity and imipenem-potentiating effects of the compounds, with molecules having a higher number of chlorine atoms potentiating the effect of imipenem at lower doses.

Artificial Biocatalytic Cascade with Three Enzymes in One Pot for Asymmetric Synthesis of Chiral Unnatural Amino Acids

Zhou, Haisheng,Meng, Lijun,Yin, Xinjian,Liu, Yayun,Xu, Gang,Wu, Jianping,Wu, Mianbin,Yang, Lirong

supporting information, p. 6470 - 6477 (2019/11/02)

Two biocatalytic reactions, transamination catalyzed by transaminases and reductive amination catalyzed by amino acid dehydrogenases, can be used for asymmetric synthesis of optically pure unnatural amino acids. However, although transaminases show a great diversity and broad substrate spectrum, most transaminase reactions are reversible, while amino acid dehydrogenases catalyze reductive amination irreversibly but with strict substrate specificity. Accordingly, herein we developed a tri-enzyme one-pot reaction system to exploit the respective advantages of transaminases and amino acid dehydrogenases, while overcoming the disadvantages of each. In this work, representatives of all four subgroups of transaminases coupled with different amino acid dehydrogenases to produce five l- and four d- unnatural amino acid products, using ammonia and the co-enzyme NAD(P)H, which is regenerated by a robust alcohol dehydrogenase with 2-propanol as cheap cosubstrate. The complete conversion and high enantiopurity (ee > 99 %) of the products, demonstrated it as an ideal alternative for asymmetric synthesis of chiral amino acid compounds.

Highly selective synthesis of d-amino acids from readily available l-amino acids by a one-pot biocatalytic stereoinversion cascade

Zhang, Danping,Jing, Xiaoran,Zhang, Wenli,Nie, Yao,Xu, Yan

, p. 29927 - 29935 (2019/10/01)

d-Amino acids are key intermediates required for the synthesis of important pharmaceuticals. However, establishing a universal enzymatic method for the general synthesis of d-amino acids from cheap and readily available precursors with few by-products is challenging. In this study, we constructed and optimized a cascade enzymatic route involving l-amino acid deaminase and d-amino acid dehydrogenase for the biocatalytic stereoinversions of l-amino acids into d-amino acids. Using l-phenylalanine (l-Phe) as a model substrate, this artificial biocatalytic cascade stereoinversion route first deaminates l-Phe to phenylpyruvic acid (PPA) through catalysis involving recombinant Escherichia coli cells that express l-amino acid deaminase from Proteus mirabilis (PmLAAD), followed by stereoselective reductive amination with recombinant meso-diaminopimelate dehydrogenase from Symbiobacterium thermophilum (StDAPDH) to produce d-phenylalanine (d-Phe). By incorporating a formate dehydrogenase-based NADPH-recycling system, d-Phe was obtained in quantitative yield with an enantiomeric excess greater than 99%. In addition, the cascade reaction system was also used to stereoinvert a variety of aromatic and aliphatic l-amino acids to the corresponding d-amino acids by combining the PmLAAD whole-cell biocatalyst with the StDAPDH variant. Hence, this method represents a concise and efficient route for the asymmetric synthesis of d-amino acids from the corresponding l-amino acids.

Chemical and Metagenomic Studies of the Lethal Black Band Disease of Corals Reveal Two Broadly Distributed, Redox-Sensitive Mixed Polyketide/Peptide Macrocycles

Gunasekera, Sarath P.,Meyer, Julie L.,Ding, Yousong,Abboud, Khalil A.,Luo, Danmeng,Campbell, Justin E.,Angerhofer, Alexander,Goodsell, Justin L.,Raymundo, Laurie J.,Liu, Junyang,Ye, Tao,Luesch, Hendrik,Teplitski, Max,Paul, Valerie J.

, p. 111 - 121 (2019/01/21)

Black band disease (BBD), a lethal, polymicrobial disease consortium dominated by the cyanobacterium Roseofilum reptotaenium, kills many species of corals worldwide. To uncover chemical signals or cytotoxins that could be important in proliferation of Roseofilum and the BBD layer, we examined the secondary metabolites present in geographically diverse collections of BBD from Caribbean and Pacific coral reefs. Looekeyolide A (1), a 20-membered macrocyclic compound formed by a 16-carbon polyketide chain, 2-deamino-2-hydroxymethionine, and d-leucine, and its autoxidation product looekeyolide B (2) were extracted as major compounds (~1 mg g-1 dry wt) from more than a dozen field-collected BBD samples. Looekeyolides A and B were also produced by a nonaxenic R. reptotaenium culture under laboratory conditions at similar concentrations. R. reptotaenium genomes that were constructed from four different metagenomic data sets contained a unique nonribosomal peptide/polyketide biosynthetic cluster that is likely responsible for the biosynthesis of the looekeyolides. Looekeyolide A, which readily oxidizes to looekeyolide B, may play a biological role in reducing H2O2 and other reactive oxygen species that could occur in the BBD layer as it overgrows and destroys coral tissue.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 328-38-1